Bruker Introduces Novel EVOQ™ DART-TQ+ for Chromatography-Free Mass Spectrometry Aimed at the Applied Market Segments Bruker Corporation highlights its commitment to develop novel technology and ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments for diseases such as cancer, Alzheimer's disease, autoimmune disorders and ...

Stifel lowered the firm’s price target on Bruker (BRKR) to $57 from $70 and keeps a Hold rating on the shares. Bruker continues to show ...

TD Cowen analyst Dan Brennan lowered the firm’s price target on Bruker (BRKR) to $55 from $70 and keeps a Hold rating on the shares. The firm ...

Bruker Daltonics is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Their high-performance scientific instruments and ...